Treatment FAQ

what is the treatment of osteoporosis in france

by Jacey Walsh Published 2 years ago Updated 2 years ago
image

Gaps in knowledge among GPs have also contributed to alarmingly low treatment rates for women with osteoporosis

Osteoporosis

A condition where bone strength weakens and is susceptible to fracture.

in France. 1 12 13 16 Research shows that only 15% of women over 50 years of age receive treatment after an initial fragility fracture, 1 and some GPs prescribe only vitamin D and calcium as treatments for osteoporosis. 8 Reasons are varied and may include poor awareness of evidence-based clinical guidelines, difficulties in understanding the benefit–risk ratio of various treatments, and time restrictions during consultations. 8

The most frequently used first-line treatments were alendronic acid (32.7 %), risedronic acid (22.4 %), strontium ranelate (19.3 %), ibandronic acid (13.1 %) and raloxifene (12.2 %).

Full Answer

What is the cost of osteoporotic fractures in the European Union?

The total spend on healthcare in the European Union amounted to €1,260 billion, with the cost of osteoporotic fractures representing 3 %.

What is the treatment gap for osteoporosis in Sweden?

Many studies have demonstrated that a significant proportion of men and women at high fracture risk do not receive therapy for osteoporosis (the treatment gap) [7]. In the EU27+2 the average treatment gap was 71% but ranged from 32 to 87%. For Sweden, the treatment gap amongst women amounted to 67% or 261,000 out of 389,000 characterised at risk.

Is bisphosphonate the best treatment for osteoporosis?

The osteoporosis market is today dominated by bisphosphonates, particularly alendronate, which has become the first-line choice in many countries given its proven efficacy and low price.

Which countries have the highest uptake of osteoporosis drugs?

In general, Southern Europe shows a higher uptake of osteoporosis drugs. There is a large gap between the number of women who are treated compared to the proportion of the population that could be considered eligible for treatment based on their fracture risk. 5.1 Uptake of osteoporosis treatment

image

What is the most popular treatment for osteoporosis?

Bisphosphonates are usually the first choice for osteoporosis treatment. These include: Alendronate (Fosamax), a weekly pill. Risedronate (Actonel), a weekly or monthly pill.

What is a good treatment option for osteoporosis?

Bisphosphonates are the kind of medicine used most often to treat osteoporosis. They do this by: Preventing bones from getting weaker by slowing the natural breakdown of bone. Lowering the risk of spine fractures and most lower the risk of hip fracture and other kinds of fractures as well.

What is the gold standard treatment for osteoporosis?

Bisphosphonates (BPs) are the pioneer and gold standard drugs for osteoporosis treatment. The development of BPs started decades ago. There are four bisphosphonates in the osteoporosis market: alendronate, risedronate, ibandronate, and zolendronate.

What is the first-line of treatment for osteoporosis?

Denosumab. The AACE/ACE recommends denosumab as first-line therapy for patients at high risk of fracture and for patients who are unable to use oral therapy. Denosumab was the first biologic agent available for treatment of osteoporosis.

What is the newest treatment for osteoporosis?

Romosozumab (Evenity). This is the newest bone-building medication to treat osteoporosis. It is given as an injection every month at your doctor's office and is limited to one year of treatment.

What is the best natural treatment for osteoporosis?

While more scientific research is needed on the subject, some herbs and supplements are believed to reduce or potentially stop the bone loss caused by osteoporosis.Red clover. Red clover is thought to contain estrogen-like compounds. ... Soy. ... Black cohosh. ... Horsetail. ... Acupuncture. ... Tai chi. ... Melatonin.

What is the best doctor to see for osteoporosis?

Osteoporosis is caused by bone loss due to hormones, so you'd actually want to see an endocrinologist to manage your care. While orthopedists do deal with other issues of the bone like joint problems and bone injuries that are symptoms of osteoporosis, endocrinologists treat the root cause.

What are at least 3 treatments for osteoporosis?

Osteoporosis treatment: Where to start pills, such as alendronate (Fosamax), ibandronate (Boniva), or risedronate (Actonel, Atelvia), taken daily, weekly, or monthly. injections of ibandronate (Boniva), given once every three months.

What is the safest injection for osteoporosis?

Boniva is the brand name for the generic drug ibandronate. Like Fosamax, Boniva is also a bisphosphonate. It is FDA-approved to prevent and treat postmenopausal osteoporosis.

What is the fastest way to increase bone density?

Keep reading for tips on increasing bone density naturally.Weightlifting and strength training. ... Eating more vegetables. ... Consuming calcium throughout the day. ... Eating foods rich in vitamins D and K. ... Maintaining a healthy weight. ... Avoiding a low calorie diet. ... Eating more protein. ... Eating foods rich in omega-3 fatty acids.More items...•

How can I increase my bone density after 60?

5 ways to build strong bones as you ageThink calcium. Women up to age 50 and men up to age 70 need 1,000 milligrams daily; women over 50 and men over 70 should get 1,200 milligrams daily.And vitamin D. ... Exercise. ... Don't smoke. ... Drink alcohol moderately, if at all. ... Remember protein. ... Maintain an appropriate body weight.

What is the name of the daily injection for osteoporosis?

Teriparatide is an osteoporosis medication prescribed to help strengthen your bones and reduce your risk of breaking a bone. It is available as a daily injection, which you do yourself. Teriparatide is prescribed for up to two years.

Osteoporosis and fragility fracture prevention in France

France is beginning to prioritise osteoporosis and the prevention of fragility fractures and falls in health policy. However, awareness and understanding of osteoporosis among healthcare professionals and patients is often poor, leading to delays in diagnosis and significant gaps in treatment.

Burden and impact of osteoporosis and fragility fractures

Osteoporosis and fragility fractures are common in France, imposing considerable costs. Over a million sick days were taken following a fragility fracture in 2017, having a negative impact on workforce productivity. 1 In France, as in other European countries, life expectancy is increasing and so is the burden of osteoporosis.

Building a system that works: policies for scrutiny, accountability and investment

Osteoporosis management and prevention of subsequent fractures are beginning to feature in national strategies. In 2017, the French Anti-Rheumatism Association (L’Association Française de Lutte Anti-Rhumatismale; AFLAR This link opens a new tab and sends you to a website not owned by Amgen (Europe) GmbH.

Catching it early: detection and management in primary care

Many primary care professionals lack the knowledge to effectively identify people with osteoporosis. 12 13 Studies have revealed that GPs in France may underestimate the associated risks 2 and may not initially consider a diagnosis of osteoporosis. 13 A 2017 survey found that 66% of GPs felt they needed to be better informed about osteoporosis.

Getting people back on track: facilitating multidisciplinary post-fracture care

One of the problems in our health system is the lack of collaboration between general practitioners, specialists and pharmacists. DIDIER POIVRET, REGIONAL HOSPITAL METZ-THIONVILLE

Supporting quality of life as part of healthy and active ageing: prevention of falls and fractures in later life

Falls prevention programmes have been initiated at local and regional levels in France, with some evidence of impact. For example, the multidisciplinary Montpellier falls prevention clinic has been shown to reduce the number of falls and fear of falling, alongside improving mobility among older patients.

Engaging patients and public: awareness, activation and self-management

People in France have difficulties in understanding the risk of osteoporosis and the disability associated with fragility fractures. Many people still believe that having a fracture when they fall is normal. THIERRY THOMAS, UNIVERSITY HOSPITAL ST ETIENNE

How many people have osteoporosis?

Twenty-two million women and 5.5 million men were estimated to have osteoporosis; and 3.5 million new fragility fractures were sustained, comprising 610,000 hip fractures, 520,000 vertebral fractures, 560,000 forearm fractures and 1,800,000 other fractures (i.e. fractures of the pelvis, rib, humerus, tibia, fibula, clavicle, scapula, sternum and other femoral fractures). The economic burden of incident and prior fragility fractures was estimated at € 37 billion. Incident fractures represented 66 % of this cost, long-term fracture care 29 % and pharmacological prevention 5 %. Previous and incident fractures also accounted for 1,180,000 quality-adjusted life years lost during 2010. The costs are expected to increase by 25 % in 2025. The majority of individuals who have sustained an osteoporosis-related fracture or who are at high risk of fracture are untreated and the number of patients on treatment is declining.

What is the main clinical consequence of osteoporosis?

Osteoporosis is characterized by reduced bone mass and disruption of bone architecture, resulting in increased risk of fragility fractures which represent the main clinical consequence of the disease. Fragility fractures are associated with substantial pain and suffering, disability and even death for affected patients and substantial costs to society. The aim of this report was to characterize the burden of osteoporosis in the EU27 in 2010 and beyond.

When was the literature on fracture incidence and costs of fractures in the EU27 reviewed?

The literature on fracture incidence and costs of fractures in the EU27 was reviewed and incorporated into a model estimating the clinical and economic burden of osteoporotic fractures in 2010.

Is osteoporosis a social cost?

In spite of the high social and economic cost of osteoporosis, a substantial treatment gap and projected increase of the economic burden driven by the aging populations, the use of pharmacological interventions to prevent fractures has decreased in recent years, suggesting that a change in healthcare policy is warranted.

How Long Should I Stay in France for a Osteoarthritis Treatment Procedure?

If you have physical and/or occupational therapy, your length of stay depends on how many visits are needed for your case. On average, you may need to stay in France for 4 to 8 weeks for therapy. With surgery, you need to stay in the hospital for 1 to 5 days, and stay at least 7 to 10 more days in the area after you are discharged.

What sort of Aftercare is Required for Osteoarthritis Treatment Procedures in France?

Your doctor should give you detailed aftercare that you will need to follow. If you undergo surgery, the aftercare may include:

What does a Osteoarthritis Treatment Procedure Involve?

For people with symptomatic knee osteoarthritis, an artificial joint fluid injection can be an option. The fluid lubricates and cushions the joint so it can move more easily. Your doctor may give you a single-dose injection into your knee joint, or you may need a series of injections.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9